News
Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...
NRx Pharmaceuticals (NASDAQ: NRXP), has submitted an Abbreviated New Drug Application (ANDA) to the FDA for NRX-100, its ...
Osaka: Takeda has received approval from the European Commission (EC) for ADCETRIS (brentuximab vedotin) in combination with ...
The European Commission (EC) has approved Adcetris (brentuximab vedotin) in combination with etoposide, cyclophosphamide, ...
Shipments include initial deliveries of SecureGard™ and SoloGard™ smart safety syringes from its Hungary-based manufacturing ...
New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...
6d
Zacks Investment Research on MSNPharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline UpdatesEli Lilly LLY announced plans to acquire SiteOne Therapeutics to expand its pain pipeline. Moderna MRNA announced that the ...
In response to the proposal presented by Fresenius Medical Care, the Subject Expert Committee (SEC) functional under the ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
DelveInsight's,“ Advanced Melanoma Pipeline Insight 2025 ” report provides comprehensive insights about 55+ companies and 60+ pipel ...
Thus Phesgo, a sub-cutaneous version of an otherwise IV breast cancer treatment ... 30 years’ experience as a consultant to the pharmaceutical industry. She has an extremely wide experience ...
Plastic pollution chokes our rivers, contaminates our food, and imperils our health. It’s a crisis demanding urgent action, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results